Botanico
Pharmaceutical-Grade Cannabis Products
Company Overview
Snapshot
Founded in December 2020, Botanico operates with 1–10 employees. The company was acquired by CANNDOC Pharma in September 2025, marking a significant milestone in its trajectory.
Business overview
Botanico is a producer and distributor of medical cannabis, dedicated to addressing patient needs and enhancing quality of life. The company focuses on research, cultivation, production, and distribution of pharmaceutical-grade cannabis products. It operates within the Health Tech & Life Sciences sector, specifically targeting the Pharma & Medical Biotechnology and Medical Cannabis markets.
Strategic signal
In September 2025, Botanico was acquired by CANNDOC Pharma. This acquisition provides the Israeli company with access to the US cannabis market, signaling a strategic expansion and potential for increased market penetration in the rapidly evolving medical cannabis industry.
Log in to access full profile ›Company Intelligence Q&A
- What is Botanico's primary focus?
- Botanico is primarily focused on the production and distribution of pharmaceutical-grade cannabis products, aiming to address patient needs and improve quality of life.
- When was Botanico founded?
- Botanico was founded in December 2020.
- What market does Botanico primarily serve?
- Botanico serves the medical cannabis market, operating within the broader Health Tech & Life Sciences sector.
- What is the employee count for Botanico?
- Botanico operates with 1–10 employees.